Creating a New Cancer Therapeutic Agent by Targeting the Interaction Between BCL-2 and IP3 Receptors
Cold Spring Harbor perspectives in biology - United States
doi 10.1101/cshperspect.a035196
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2019
Authors
Publisher
Cold Spring Harbor Laboratory